

Name | Size/Type | Description | Date |
---|---|---|---|
01 SACT algorithm for early stage breast cancer | 1021KB PDF | 01 SACT algorithm for early stage breast cancer | 14 May 2024 |
Abemaciclib + aromatase inhibitor | 181KB PDF | Abemaciclib + aromatase inhibitor | 18 Apr 2023 |
Accelerated EC - Accelerated Paclitaxel | 189KB PDF | Accelerated EC - Acc Paclitaxel | 09 Sep 2020 |
Accelerated EC x 4, Carboplatin & Paclitaxel x 4 | 150KB PDF | Accelerated EC x 4, Carboplatin & Paclitaxel x 4 | 08 Jul 2022 |
Accelerated EC- Docetaxel | 159KB PDF | Accelerated EC- Docetaxel | 18 Jun 2021 |
Capecitabine | 140KB PDF | Capecitabine | 21 Apr 2020 |
Carboplatin Paclitaxel X4 EC x 4 with Pembrolizumab in TNBC | 162KB PDF | Carboplatin Paclitaxel X4 EC x 4 with Pembrolizumab in TNBC | 11 Jan 2023 |
Docetaxel & Carboplatin for HER2+ve breast cancer | 156KB PDF | Docetaxel & Carboplatin for HER2+ve breast cancer | 08 Jul 2022 |
Docetaxel & Carboplatin for TNBC | 318KB PDF | Docetaxel & Carboplatin for TNBC | 17 Oct 2022 |
Docetaxel & Cyclophosphamide | 80KB PDF | Docetaxel & Cyclophosphamide | 21 Apr 2020 |
EC | 100KB PDF | EC | 21 Jun 2021 |
EC-Docetaxel (6 cycles total) | 117KB PDF | EC-Docetaxel (6 cycles total) | 14 Sep 2023 |
Nab-Paclitaxel (Abraxane) | 144KB PDF | Nab-Paclitaxel (Abraxane) | 21 Apr 2020 |
Neratinib for extended adjuvant use | 143KB PDF | Neratinib for extended adjuvant use | 02 Sep 2020 |
Olaparib | 146KB PDF | Olaparib | 21 Mar 2025 |
Paclitaxel weekly x 12 for EBC | 101KB PDF | Paclitaxel weekly x 12 for EBC | 13 Oct 2020 |
Phesgo (Pertuzumab +Trastuzumab Subcutaneous) | 171KB PDF | Phesgo (Pertuzumab + Trastuzumab subcut) | 26 Mar 2021 |
Trastuzumab (Herceptin) subcutaneous | 148KB PDF | Trastuzumab (Herceptin) subcutaneous | 30 Mar 2021 |
Trastuzumab (Ontruzant) IV | 149KB PDF | Trastuzumab (Ontruzant) IV | 21 Apr 2020 |
Trastuzumab Emtansine (Kadcyla) Adjuvant | 137KB PDF | Trastuzumab Emtansine (Kadcyla) Adjuvant | 28 Jan 2022 |